感染症体外診断薬の世界市場（2024年版）：技術別（免疫測定、分子診断、微生物学、その他の技術）、製品タイプ別、エンドユーザー別、地域別、国別の分析：市場インサイトと予測（2020-2030年）

Global Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

エグゼクティブ・サマリーこの調査レポートは世界の感染症体外診断市場を分析・予測したもので、技術別（免疫測定法、分子診断法、微生物学、その他の技術）、製品タイプ別（機器、試薬、サービス）、エンド... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Azoth Analytics アーゾスアナリティクス	2024年4月1日	US$2,450 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	261	英語

サマリー

エグゼクティブ・サマリー

この調査レポートは世界の感染症体外診断市場を分析・予測したもので、技術別（免疫測定法、分子診断法、微生物学、その他の技術）、製品タイプ別（機器、試薬、サービス）、エンドユーザー別（Point of care、中央検査室、その他のエンドユーザー）を掲載し、2020-2023年の過去期間、2024年の予測期間、2025-2030年の予測期間を掲載しています。

本レポートでは、感染症体外診断薬の世界市場を地域別（南北アメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ）、10カ国別（アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド）に分析しています。世界の感染症体外診断市場は、2020-2023年にCAGR 2.45 %の成長を示しました。2023年の市場規模は658億6,000万ドルで、2030年には803億1,000万ドルに達すると予測される。

感染症の体外診断の世界市場には、感染症の検出と管理に使用される幅広い診断検査と技術が含まれる。これには
これには、ヒトに感染症を引き起こす原因となる細菌、ウイルス、真菌、寄生虫などの病原体を同定するために設計された様々なアッセイ、機器、試薬が含まれる。
これらの診断ツールは、世界中の疾病サーベイランス、アウトブレイク・コントロール、患者管理、公衆衛生介入において重要な役割を果たしている。

感染症体外診断薬市場は、感染症の蔓延、迅速かつ正確な診断ソリューションに対する需要の高まり、診断技術の進歩、疾患の早期発見・早期介入の重要性に対する意識の高まりなど、いくつかの要因によって牽引されている。さらに、グローバル化、都市化、人口増加、環境変化などの要因が感染性病原体の蔓延を助長し、診断検査・ツールに対する需要をさらに高めている。

同市場は、診断薬メーカー、バイオテクノロジー企業、医療機関を含む主要企業間の激しい競争が特徴である。これらの企業は
これらの企業は、医療提供者、検査室、患者の進化するニーズに対応するため、新製品やソリューションを継続的に革新し、発表している。

レポートの範囲
- 本レポートでは、世界の感染症体外診断薬市場を金額（10億米ドル）別に分析しています。
- 2020-2023年の過去期間、2024年の推定期間、2025-2030年の予測期間における感染症体外診断薬の世界市場の分析を掲載しています。
- 感染症体外診断薬の世界市場を地域別（南北アメリカ、ヨーロッパ、アジア太平洋地域、中東・アフリカ）、10ヶ国別（アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド）に分析しています。
- 感染症体外診断薬の世界市場を技術別（免疫測定法、分子診断法、微生物学、その他の技術）に分析しています。
- 感染症体外診断薬の世界市場を製品タイプ別（機器、試薬、サービス）に分析したレポートです。
- 感染症体外診断薬の世界市場をエンドユーザー別（Point of care、中央検査室、その他のエンドユーザー）に分析しています。
- 本レポートの主要な洞察は、SWOTおよびポーターのファイブフォース分析の枠組みを通して提示されています。また、市場の魅力を地域別、技術別、製品タイプ別、エンドユーザー別に紹介しています。
- また、業界の主な機会、動向、促進要因、課題についても分析しています。
- 本レポートでは、競合の動向、戦略、M&A、新製品開発などを追跡しています。本レポートで分析対象とした企業は、QIAGEN、F. Hoffmann-La Roche AG、OraSure technologies、PerkinElmer Inc.、Abbott Laboratories、Thermo Fisher、Becton, Dickinson and Company、Hologic, Inc.、Danaher Corporation、Bio-Rad Laboratoriesなどです。

ページTOPに戻る

Table of Content

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Analyst Recommendations
2.1 Investment in Education and Training
2.2 Leveraging Artificial Intelligence for Advancements in Infectious Disease In-Vitro Diagnostics

3. Global Infectious Disease In vitro Diagnostics Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Global Infectious Disease In vitro Diagnostics Market
3.2 Global Prevalence of Infectious Disease, 2019
3.3 Global Incidence of Infectious Disease, 2019
3.4 New cases of tuberculosis with uncertainty intervals, World (2020-2022)
3.5 SARS-Cov-2 Tests: Volumes 2020
3.6 Global Infectious Disease In vitro Diagnostics Market: Dashboard
3.7 Global Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
3.8 Global Infectious Disease In vitro Diagnostics Market: Market Value Assessment
3.9 Assessment Degree of Impact of COVID-19 on Global Infectious Disease In vitro Diagnostics Market
3.10 Global Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
3.10.1 Global Infectious Disease In vitro Diagnostics Market, By Technology Overview
3.10.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By Technology
3.10.3 Global Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.4 Global Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.5 Global Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.6 Global Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
3.11 Global Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
3.11.1 Global Infectious Disease In vitro Diagnostics Market, By Product Type Overview
3.11.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By Product Type
3.11.3 Global Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.4 Global Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.5 Global Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
3.12 Global Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
3.12.1 Global Infectious Disease In vitro Diagnostics Market, By End-users Overview
3.12.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By End-users
3.12.3 Global Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
3.12.4 Global Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
3.12.5 Global Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Infectious Disease In vitro Diagnostics Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Infectious Disease In vitro Diagnostics Market: Historic and Forecast
5.1 Americas Infectious Disease In vitro Diagnostics Market: Snapshot
5.2 Americas Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.3 Americas Infectious Disease In vitro Diagnostics Market: Key Factors
5.4 Americas Infectious Disease In vitro Diagnostics Market: Segment Analysis
5.5 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
5.5.1 Americas Infectious Disease In vitro Diagnostics Market, By Technology Overview
5.5.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.5 Americas Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
5.6.1 Americas Infectious Disease In vitro Diagnostics Market, By Product Type Overview
5.6.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
5.7.1 Americas Infectious Disease In vitro Diagnostics Market, By End-users Overview
5.7.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Country
5.8.1 Americas Infectious Disease In vitro Diagnostics Market, by Country Overview
5.8.2 United States Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.2.1 United States Infectious Disease In vitro Diagnostics Market, By Technology
5.8.2.2 United States Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.2.3 United States Infectious Disease In vitro Diagnostics Market, By End-users
5.8.3 Canada Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.3.1 Canada Infectious Disease In vitro Diagnostics Market, By Technology
5.8.3.2 Canada Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.3.3 Canada Infectious Disease In vitro Diagnostics Market, By End-users
5.8.4 Rest of Americas Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.4.1 Rest of Americas Infectious Disease In vitro Diagnostics Market, By Technology
5.8.4.2 Rest of Americas Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.4.3 Rest of Americas Infectious Disease In vitro Diagnostics Market, By End-users

6. Europe Infectious Disease In vitro Diagnostics Market: Historic and Forecast
6.1 Europe Infectious Disease In vitro Diagnostics Market: Snapshot
6.2 Europe Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.3 Europe Infectious Disease In vitro Diagnostics Market: Key Factors
6.4 Europe Infectious Disease In vitro Diagnostics Market: Segment Analysis
6.5 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
6.5.1 Europe Infectious Disease In vitro Diagnostics Market, By Technology Overview
6.5.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.5 Europe Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
6.6.1 Europe Infectious Disease In vitro Diagnostics Market, By Product Type Overview
6.6.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
6.7.1 Europe Infectious Disease In vitro Diagnostics Market, By End-users Overview
6.7.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.4 Europe Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Country
6.8.1 Europe Infectious Disease In vitro Diagnostics Market, by Country Overview
6.8.2 Germany Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.2.1 Germany Infectious Disease In vitro Diagnostics Market, By Technology
6.8.2.2 Germany Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.2.3 Germany Infectious Disease In vitro Diagnostics Market, By End-users
6.8.3 United Kingdom Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.3.1 United Kingdom Infectious Disease In vitro Diagnostics Market, By Technology
6.8.3.2 United Kingdom Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.3.3 United Kingdom Infectious Disease In vitro Diagnostics Market, By End-users
6.8.4 France Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.4.1 France Infectious Disease In vitro Diagnostics Market, By Technology
6.8.4.2 France Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.4.3 France Infectious Disease In vitro Diagnostics Market, By End-users
6.8.5 Italy Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.5.1 Italy Infectious Disease In vitro Diagnostics Market, By Technology
6.8.5.2 Italy Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.5.3 Italy Infectious Disease In vitro Diagnostics Market, By End-users
6.8.6 Spain Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.6.1 Spain Infectious Disease In vitro Diagnostics Market, By Technology
6.8.6.2 Spain Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.6.3 Spain Infectious Disease In vitro Diagnostics Market, By End-users
6.8.7 Rest of Europe Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.7.1 Rest of Europe Infectious Disease In vitro Diagnostics Market, By Technology
6.8.7.2 Rest of Europe Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.7.3 Rest of Europe Infectious Disease In vitro Diagnostics Market, By End-users

7. Asia Pacific Infectious Disease In vitro Diagnostics Market: Historic and Forecast
7.1 Asia Pacific Infectious Disease In vitro Diagnostics Market: Snapshot
7.2 Asia Pacific Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Infectious Disease In vitro Diagnostics Market: Key Factors
7.4 Asia Pacific Infectious Disease In vitro Diagnostics Market: Segment Analysis
7.5 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
7.5.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology Overview
7.5.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.6 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
7.6.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type Overview
7.6.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
7.7.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users Overview
7.7.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.4 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Country
7.8.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, by Country Overview
7.8.2 China Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.2.1 China Infectious Disease In vitro Diagnostics Market, By Technology
7.8.2.2 China Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.2.3 China Infectious Disease In vitro Diagnostics Market, By End-users
7.8.3 Japan Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.3.1 Japan Infectious Disease In vitro Diagnostics Market, By Technology
7.8.3.2 Japan Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.3.3 Japan Infectious Disease In vitro Diagnostics Market, By End-users
7.8.4 India Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.4.1 India Infectious Disease In vitro Diagnostics Market, By Technology
7.8.4.2 India Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.4.3 India Infectious Disease In vitro Diagnostics Market, By End-users
7.8.5 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.5.1 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology
7.8.5.2 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.5.3 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users

8. Middle East and Africa Infectious Disease In vitro Diagnostics Market: Historic and Forecast
8.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Snapshot
8.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Key Factors
8.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Segment Analysis
8.5 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
8.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Technology Overview
8.5.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.5 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
8.6.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Product Type Overview
8.6.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
8.7.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By End-users Overview
8.7.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Infectious Disease In vitro Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis
10.1 Porter Analysis

11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Global Infectious Disease In vitro Diagnostics Market
11.4 Company Profiles
11.4.1 QIAGEN
11.4.2 F. Hoffmann-La Roche AG
11.4.3 OraSure technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 Thermo Fisher
11.4.7 Becton, Dickinson and Company
11.4.8 Hologic, Inc.
11.4.9 Danaher Corporation
11.4.10 Bio-Rad Laboratories

12. About Us & Disclaimer

ページTOPに戻る

Table of Contents

Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Infectious Disease In vitro Diagnostics Market (2024 Edition)” which provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type (Instruments, Reagents, and Services) By End Users (Point of care, Central Laboratories, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Infectious Disease In vitro Diagnostics Market showcased growth at a CAGR of 2.45 % during 2020-2023. The market was valued at USD 65.86 Billion in 2023 which is expected to reach USD 80.31 Billion in 2030.

The global market for infectious disease in-vitro diagnostics encompasses a wide range of diagnostic tests and technologies used for the detection and management of infectious diseases. It
includes various assays, instruments, and reagents designed to identify pathogens, such as bacteria, viruses, fungi, and parasites, responsible for causing infectious illnesses in humans.
These diagnostic tools play a crucial role in disease surveillance, outbreak control, patient management, and public health interventions worldwide.

The market for infectious disease in-vitro diagnostics is driven by several factors, including the increasing prevalence of infectious diseases, rising demand for rapid and accurate diagnostic solutions, advancements in diagnostic techno*logies, and growing awareness about the importance of early disease detection and intervention. Additionally, factors such as globalization, urbanization, population growth, and environmental changes contribute to the spread of infectious pathogens, further fueling the demand for diagnostic tests and tools.

The market is characterized by intense competition among key players, including diagnostic manufacturers, biotechnology companies, and healthcare organizations. These companies are
continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:
• The report analyses the Global Infectious Disease In vitro Diagnostics Market by Value (USD Billion).
• The report presents the analysis of Global Infectious Disease In vitro Diagnostics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Global Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies)
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By Product Type (Instruments, Reagents, and Services).
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By End Users (Point of care, Central Laboratories, and Other End Uses).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Technology, By Product Type and By End User.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include QIAGEN, F. Hoffmann-La Roche AG, OraSure technologies, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation, and Bio-Rad Laboratories

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（診断薬）の最新刊レポート

Azoth Analytics 社の最新刊レポート

本レポートと同じKEY WORD（immunoassay）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

感染症体外診断薬の世界市場（2024年版）：技術別（免疫測定、分子診断、微生物学、その他の技術）、製品タイプ別、エンドユーザー別、地域別、国別の分析：市場インサイトと予測（2020-2030年）

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（診断薬）の最新刊レポート

Azoth Analytics 社の最新刊レポート

本レポートと同じKEY WORD（immunoassay）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?